Phospholipase C and Src modulate angiotensin II-induced cyclic AMP production in preglomerular microvascular smooth-muscle cells from spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 2, 2007, Pages 106-110

  Jackson, Edwin K ^a   Gillespie, Delbert G ^a   Jackson, Travis C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylyl cyclase; cAMP; Phospholipase Cs; Src kinases; Vascular smooth muscle

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ANGIOTENSIN II; CYCLIC AMP; HEMATOPOIETIC CELL KINASE; PHOSPHOLIPASE C; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN KINASE LYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HEART MUSCLE CELL; MALE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN VARIANT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND MESSENGER; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

1-METHYL-3-ISOBUTYLXANTHINE; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; ESTRENES; ISOENZYMES; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; PYRROLIDINONES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, FLUORESCENCE; SRC-FAMILY KINASES;

EID: 33847189581     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31802ee3d5     Document Type: Article

References (38)

1. Lincoln TM, Cornwell TL. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels. 1991;28:129-137.
2. Mooradian DL, Fernandes B, Diglio CA, et al. Angiopeptin (BIM23014C) inhibits vascular smooth muscle cell migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation. J Cardiovasc Pharmacol. 1995;25:611-618.
3. Newman WH, Castresana MR, Webb JG, et al. Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. J Surg Res. 2003;109:57-61.
4. Kip1. Cardiovasc Res. 2001;52:500-508.
5. Kronemann N, Nockher WA, Busse R, et al. Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression. Br J Pharmacol. 1999;126:349-357.
6. Schroer K, Zhu Y, Saunders MA, et al. Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation. 2002;105:2760-2765.
7. Vyas SJ, Mi Z, Jackson EK. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney. J Pharmacol Exp Ther. 1996;279:114-149.
8. Tintut Y, Patel J, Parhami F, et al. Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636-2642.
9. Soderling SH, Beavo JA. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol. 2000;12:174-179.
10. Sunahara RK, Dessauer CW, Gilman AG. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol. 1996;36:461-480.
11. Schwartz JH. The many dimensions of cAMP signaling. Proc Natl Acad Sci U S A. 2001;98:13482-13484.
12. Jackson TC, Mi Z, Jackson EK. Modulation of cyclic AMP production by signal transduction pathways in preglomerular microvessels and microvascular smooth muscle cells. J Pharmacol Exp Ther. 2004;310:349-358.
13. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclicnucleotides and angiotensin1 receptors. J Clin Invest. 1995;96:141-149.
14. Nagata D, Takeda R, Sata M, et al. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation. 2004;110:444-451.
15. Dechend R, Fiebler A, Lindschau C, et al. Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition. Am J Hypertens. 2001;14:55S-61S.
16. Balla T, Varnai P, Tian Y, et al. Signaling events activated by angiotensin II receptors: what goes before and after the calcium signals. Endocr Res. 1998;24:335-344.
17. Ishida M, Ishida T, Thomas S, et al. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res. 1998;82:7-12.
18. Burnay MM, Vallotton MB, Capponi AM, et al. Angiotensin II potentiates adrenocorticotrophic hormone-induced cAMP formation in bovine adrenal glomerulosa cells through a capacitative calcium influx. Biochem J. 1998;330:21-27.
19. Hagiwara H, Hiruma Y, Inoue A, et al. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol. 1998;156:543-550.
20. Mededovic S, Fraser LR. Angiotensin II stimulates cAMP production and protein tyrosine phosphorylation in mouse spermatozoa. Reproduction. 2004;127:601-612.
21. Burns KD, Regnier L, Roczniak A, et al. Immortalized rabbit cortical collecting duct cells express AT1 angiotensin II receptors. Am J Physiol Renal Physiol. 1996;271:F1147-F1157.
22. Hussain T, Abdul-Wahab R, Kotak DK, et al. Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension. 1998;32:1054-1059.
23. Izevbigie EB, Gutkind JS, Ray PE. Angiotensin II and basic fibroblast growth factor mitogenic pathways in human fetal mesangial cells. Pediatr Res. 2000;47:614-621.
24. 1A receptors. Am J Physiol Renal Physiol. 1996;271:F1020-F1028.
25. Mokkapatti R, Vyas SJ, Romero GG, et al. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther. 1998;287:223-231.
26. Nakamura A, Johns EJ, Imaizumi A, et al. Role of angiotensin II-induced cAMP in mesangial TNF-α production. Cytokine. 2002;19:47-51.
27. Cheng HS, So SC, Law SH, et al. Angiotensin II-mediated signal transduction events in cystic fibrosis pancreatic duct cells. Biochim Biophys Acta. 1999;1449:254-260.
28. Schutzer WE, Xue H, Reed JF, et al. Angiotensin II enhances β-adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats. Am J Physiol Heart Circ Physiol. 2000;279:H2807-H2814.
29. Katan M, Rodriguez R, Matsuda M, et al. Structural and mechanistic aspects of phospholipase Cg regulation. Adv Enzyme Regul. 2003;43:77-85.
30. 2-adrenoceptor interaction. J Pharmacol Exp Ther. 2005;314:1109-1116.
31. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene. 2004;23:7918-7927.
32. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513-609.
33. Hanke JH, Gardner JP, Dow RL, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem. 1996;271:695-701.
34. Marrero MB, Paxton WG, Schieffer B, et al. Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell Signal. 1996;8:21-26.
35. Yin G, Yan C, Berk BC. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol. 2003;35:780-783.
36. Schelling JR, Nkemere N, Konieczkowski M, et al. Angiotensin II activates the β1 isoform of phospholipase C in vascular smooth muscle cells. Am J Physiol Cell Physiol. 1997;272:C1558-C1566.
37. 12, and βγG protein subunits. J Biol Chem. 1998;273:19772-19777.
38. Luttrell DK, Hausdorff WP, Moyers JE, et al. Overexpression of pp60c-src is associated with altered regulation of adenylyl cyclase. Cell Signal. 1992;4:531-541.